Alembic Pharmaceuticals received USFDA approval for its Sumatriptan injection, a generic equivalent for treating migraines and cluster headaches. This marks Alembic's first drug device combination.

Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration ...

Ltd on Monday said it has received final approval from the US health regulator for its generic version of Sumatriptan injection used in treatment of migraine.   The approval by the US Food & Drug ...

Interior Health registered nurse Ilka Chobanova is a testament to how evidence-based best practices can improve patient ...

Unapproved peptide drugs have become a trendy new hack among wellness influencers, fitness coaches and celebrities, pitched as a way to build muscle, shed pounds and look younger. (AP video/produced b ...

Once-daily, steroid-free topical foam intentionally formulated to help manage psoriasis across difficult-to-treat areas of ...

Indian stocks ended higher on Monday, with the Sensex and Nifty mirroring gains across Asian markets amid optimism that ...

Detailed price information for Aim Immunotech Inc (AIM-A) from The Globe and Mail including charting and trades.

As of September 30, 2025, Tonix had $190.1 million in cash and cash equivalents, compared with $98.8 million as of December 31, 2024. Net cash used in operations was approximately $60.2 million for ...

Vadodara: Pharma firm Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New ...

Among sectors, metal index added 1.4%, while Consumer Durables, FMCG, telecom shed 0.5% each. BSE midcap and smallcap indices ended with marginal gains. Shriram Finance, Adani Enterprises, Tata Steel, ...